Find your path to Mark
272 people in our graph share verified history with Mark — schools, employers, funds. One of them is your warm intro.
Anthony PhilippakisunlockedMark: together at Harvard Medical School (2001–2009)
×4Mark: together at Harvard Medical School
×5Mark: together at Massachusetts General Hospital
Mark: together at Sage Therapeutics
About
Mark Pollack, MD is Chief Medical Officer at Reunion Neuroscience. He previously served as SVP for Global Medical Affairs at Sage Therapeutics and CMO for Neuroscience at Myriad Genetics, and before entering industry he chaired the Department of Psychiatry and Behavioral Sciences at Rush University Medical Center and directed the Center for Anxiety and Traumatic Stress Disorders at Massachusetts General Hospital, where he was also Professor of Psychiatry at Harvard Medical School. A past President of the Anxiety and Depression Association of America with over 500 publications, he graduated from the University of Virginia, earned his MD at New Jersey Medical School, and completed his residency and fellowship in psychiatry at MGH and Harvard Medical School.
Executive at Reunion Neuroscience
Intro paths
→
In turn, Mark can intro founders to Reunion Neuroscience's investors below.
Experience
- Reunion NeuroscienceChief Medical Officercurrent2024 — present
- Biopharmaceutical ConsultingBiopharmaceutical Consultingcurrent2023 — present
- Argus CognitiveMember Board of Directorscurrent2017 — present
- Sage TherapeuticsSenior Vice President, Global Medical Affairs2022 — 2023
- Myriad NeuroscienceChief Medical Officer and Vice President2020 — 2022
- Rush University Medical CenterProfessor and Chairman of Psychiatry and Behavioral Sciences2011 — 2020Chicago, Il
- Harvard Medical SchoolProfessor of Psychiatry1985 — 2011Boston, MA
- Massachusetts General HospitalDirector, Center for Anxiety and Traumatic Stress Disorders1982 — 2011Boston, MA
Skills & more
Strategy2Cognition11ManagementLeadershipTranslational Research3Psychiatry99Medicine99Clinical Research99Mental Health99Healthcare60Treatment78Neuroscience99
+12 more
Medical EducationPsychologyClinical DevelopmentPsychopharmacologyBoard CertifiedBehavioral HealthClinical SupervisionClinical TrialsHealthcare ManagementHospitalsMedical ResearchResearchFrom Mark's professional profile.
Frequently asked questions
- Who is Mark Pollack?
- Mark Pollack, MD is Chief Medical Officer at Reunion Neuroscience. He previously served as SVP for Global Medical Affairs at Sage Therapeutics and CMO for Neuroscience at Myriad Genetics, and before entering industry he chaired the Department of Psychiatry and Behavioral Sciences at Rush University Medical Center and directed the Center for Anxiety and Traumatic Stress Disorders at Massachusetts General Hospital, where he was also Professor of Psychiatry at Harvard Medical School. A past President of the Anxiety and Depression Association of America with over 500 publications, he graduated from the University of Virginia, earned his MD at New Jersey Medical School, and completed his residency and fellowship in psychiatry at MGH and Harvard Medical School.
- Where does Mark Pollack work?
- Mark Pollack is Executive at Reunion Neuroscience.
- Where did Mark Pollack go to school?
- Mark Pollack studied at Harvard Medical School (Psychiatry Residency Program); Rutgers New Jersey Medical School (MD, Medicine); University of Virginia (BA).
Same school
Also attended Harvard Medical School328
Niko BonatsosFounder and Managing Partner of VerdictAnthony PhilippakisInvestor at GV (Google Ventures)Ben RobbinsInvestor at GV (Google Ventures)David ReshefInvestor at GV (Google Ventures)Krishna YeshwantInvestor at GV (Google Ventures)Morgan CheathamPartner and Head of Healthcare and Life Sciences at Breyer Capital
+ 322 more
Also attended Rutgers New Jersey Medical School4
Also attended University of Virginia804
Alexis OhanianFounder & General Partner of Seven Seven SixAndy FligelSenior Managing Director at Intel CapitalKandace ElamVice President of GTM Talent at Menlo VenturesTrevor KienzleInvestor at Correlation VenturesLauren von ReynInvestor at LightbankFrank RotmanCo-Founder and Partner Emeritus at QED Investors
+ 798 more
Shared employers
Also worked at Sage Therapeutics10
Jeffrey M. JonasPartner at Cure VenturesAlbert J. RobichaudPartner at Cure VenturesKiran ReddySenior Managing Director at Blackstone Life SciencesJamil BegPartner at 5AM VenturesAsha NayakInvestor at Johnson & Johnson Innovation – JJDCMatthew CalistriManaging Director at Bain Capital Life Sciences
+ 4 more
Also worked at Rush University Medical Center9
Sam YaganCo-Founder and Managing Director at Corazon CapitalNicole WalkerSenior Advisor at 2Flo VenturesJesse RiveraConsulting at Rock HealthEric AlvarezExecutive Officer, Director at GrapefruitShanti BansalFounder & MD at Octagos HealthDennis KimFounder at Xeno Biosciences
+ 3 more
Also worked at Harvard Medical School336
Logan HilleLife Sciences Analyst at CincyTechAnkit GuptaGeneral Partner at Y CombinatorDavid MollerInvestor at Third Rock VenturesSamuel ArbesmanVenture Partner at Lux CapitalZach CollinsPartner at Mission BiocapitalAlexi Nazem, MDGeneral Partner at AlleyCorp
+ 330 more
Also worked at Massachusetts General Hospital129
Ben RobbinsInvestor at GV (Google Ventures)Erin MooreInvestor at Third Rock VenturesJeb KeiperInvestor at Third Rock VenturesJefte DrijversInvestor at Third Rock VenturesDan GebremedhinPartner at Flare Capital PartnersRochelle WalenskyExecutive Partner at Flare Capital Partners
+ 123 more